miR-128 plays a negative regulatory role in the SNAI1/miR-128/SP1 axis, counteracting this role of SNAI1 in promoting glioma progression and inhibiting glioma aggressiveness (Dong et al., 2014). Here, SP1 is linked to central nervous system cancer.